Sierra Summit Advisors’s UroGen Pharma URGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-14,515
Closed -$218K 220
2023
Q4
$218K Buy
+14,515
New +$218K 0.06% 181